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Abstract
Background: Nosocomial infection (NI), particularly with positive blood or cerebrospinal fluid
bacterial cultures, is a major cause of morbidity in neonatal intensive care units (NICUs). Rates of
NI appear to vary substantially between NICUs. The aim of this study was to determine risk factors
for NI, as well as the risk-adjusted variations in NI rates among Canadian NICUs.
Methods:  From January 1996 to October 1997, data on demographics, intervention, illness
severity and NI rates were submitted from 17 Canadian NICUs. Infants admitted at <4 days of age
were included. NI was defined as a positive blood or cerebrospinal fluid culture after > 48 hrs in
hospital.
Results: 765 (23.5%) of 3253 infants <1500 g and 328 (2.5%) of 13228 infants ≥ 1500 g developed
at least one episode of NI. Over 95% of episodes were due to nosocomial bacteremia. Major
morbidity was more common amongst those with NI versus those without. Mortality was more
strongly associated with NI versus those without for infants ≥ 1500 g, but not for infants <1500 g.
Multiple logistic regression analysis showed that for infants <1500 g, risk factors for NI included
gestation <29 weeks, outborn status, increased acuity on day 1, mechanical ventilation and
parenteral nutrition. When NICUs were compared for babies <1500 g, the odds ratios for NI
ranged from 0.2 (95% confidence interval [CI] 0.1 to 0.4) to 8.6 (95% CI 4.1 to 18.2) when
compared to a reference site. This trend persisted after adjustment for risk factors, and was also
found in larger babies.
Conclusion: Rates of nosocomial infection in Canadian NICUs vary considerably, even after
adjustment for known risk factors. The implication is that this variation is due to differences in
clinical practices and therefore may be amenable to interventions that alter practice.
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Background
Hospital acquired (nosocomial) infection in neonatal
intensive care units (NICUs) is a significant cause of mor-
tality and morbidity, particularly in very low birth weight
(VLBW, <1500 g) babies. VLBW infants when affected by
these infections are at increased risk for death, have a
longer hospital stay, and utilize more resources than non-
affected controls [1]. The 15 participating centres in the
National Institute of Child Health and Human Develop-
ment Neonatal Research Network found that 11% to 32%
(mean 21%) of VLBW infants have at least one episode of
nosocomial sepsis [2]. Similar variations have been
described in other datasets [3,4]. These studies also
showed that valid comparisons of rates of nosocomial
sepsis between centres require adjustment for risk factors,
such as patient demographics and admission illness
severity.
Risk-adjustment has also been used to look at variations
in rates of both neonatal mortality and morbidity [5]. For
example, it has been shown that, after correcting for a
number of confounders, Canadian NICUs vary signifi-
cantly in their rates of death, catheter-related sepsis and
intraventricular hemorrhage [6-8]. Each of these authors
concluded that differences in outcome may be partly
attributable to practice variation. Given the complexity
and intensity of care provided to VLBW infants, it is likely
that the etiology of acquired infections in NICUs is multi-
factorial [9], with risk arising from the factors attributable
to the host, the organism, the environment and clinical
interventions. However, previous studies only examined
risk factors for hospital-acquired infections in VLBW
infants. It is unclear whether risk factors are different in
larger infants with 1500 g or higher birth weights (HBW)
admitted to the NICU.
The aims of this study were to examine (a) risk factors for
culture-proven hospital acquired infections for VLBW and
HBW infants admitted to the NICU, (b) the risks associ-
ated with specific clinical interventions in the NICU and
(c) the risk-adjusted variations in hospital acquired infec-
tion rates among Canadian NICUs.
Methods
Study population
The study cohort included all infants admitted to 17
Canadian NICUs prior to 4 days of age. Neonates without
a recorded birthweight were excluded. The study cohort
was derived from a larger study of 9506 babies admitted
to 17 tertiary NICUs in the Canadian Neonatal Network
from January 1996 through to October 1997 [10]. These
units represent approximately three-quarters of all the ter-
tiary NICU beds in Canada, a nation with >350 000 births
annually and almost 30 million people [11,12]. Informa-
tion about these neonates was prospectively collected by
trained abstractors with standardized definitions and
operations as part of the larger study of Canadian NICUs
[10].
Variable definitions
For the purpose of this study, nosocomial infection (or
NI) was defined as one or more positive single organism
blood or CSF culture sampled after 48 h of admission in
an infant with clinical suspicion of infection. To differen-
tiate between nosocomial and primary (maternal origin)
infections, the infant blood culture isolates were required
to be different from maternal isolates or to occur at least 7
days after a treated positive blood culture obtained during
the first 48 h of life. CSF samples were obtained when
indicated according to local practices and policies. The
time period of 2 days was chosen to exclude any neonates
born with primary infection. Absence of NI included
those infants who were never cultured and those with neg-
ative blood and/or CSF cultures. An infection episode was
defined as a positive culture occurring at least 7 days after
a previous treated culture or if the culture isolates were dif-
ferent from the previous culture [13]. We defined nosoco-
mial infections (NI) in this way because blood and CSF
are normally sterile, thus a positive culture from one of
these sites in an unwell baby is likely to be of serious clin-
ical significance. Additionally, from a practical perspec-
tive, these data are well defined and readily abstracted
from patient charts.
Other study definitions were in accordance with the Cana-
dian Neonatal Network Data Abstractor's Manual [14]:
gestational age was defined as the attending obstetrician's
best estimate based on obstetric history and examination,
and prenatal ultrasound, except where this was not avail-
able or the postnatal physical assessment disagreed with
obstetrical estimate by greater than 2 weeks. In that case,
the pediatric estimate of gestational age was used instead.
Small for gestational age meant being born below the 3rd
percentile for weight (corrected for gestation using growth
charts developed by Whitfield et al [15]). Major congeni-
tal and chromosomal anomalies were specified in the
Abstractor's Manual. Outborn infants were those born at
a different hospital from the admitting NICU. The Score
for Neonatal Acute Physiology, Version II (SNAP-II) was
collected on day 1 as a measure of patient acuity on the
day of admission. The SNAP-II is a validated score [16]
using 6 empirically weighted physiological measurements
made during the first 12 hours after admission to the
NICU. To be consistent with previous reports, SNAP-II
score was categorized as 0 to 9, 10 to 19, 20 to 29 and
greater or equal to 30. Therapy related risk factors were
extracted from day-1 and day-3 evaluations, using a subset
of relevant variables from the Neonatal Therapeutic Inten-
sity Scoring System (NTISS) [17]. The subset of variables
included the use of assisted ventilation, peripheralBMC Pediatrics 2005, 5:22 http://www.biomedcentral.com/1471-2431/5/22
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intravenous (IV) access, central venous access, arterial line
access, use of antibiotics (day 1 or 3), gavage feeding,
intravenous amino acids, and intravenous fat emulsion.
Data analysis
Univariate and bivariate analyses using SPSS (Chicago,
Illinois) were used to describe the study population and
to explore the relationships between baseline population
risks (gestational age, birth weight, gender, Apgar score at
5 minutes, small for gestational age, use of antenatal cor-
ticosteroids, multiple births, outborn status, caesarean
section, maternal hypertension, congenital anomalies,
admission illness severity) and NI. Chi-square test was
used to compare mortality and morbidity among infants
with and without NI, for infants with birth weight less
than 1500 g and 1500 g or more.
We used a multivariable logistic regression model to
develop a risk adjustment model for NI. The outcome var-
iable was NI and independent variables were baseline
population risks significantly correlated with NI on bivar-
iate analysis. Correlation matrix was used to examine cor-
relation between variables. The full model was created by
adding population risk factors, then SNAP-II score, and
finally therapy-related factors – variables were considered
to be included if their p-value was <0.10. Backward and
forward selections from the full model were applied to
help determine the parsimonious model. Finally, centres
were compared using adjusted odds ratios and 95% con-
fidence intervals derived from the multivariable logistic
regression analysis, using a reference centre (the hospital
with the median incidence of nosocomial infection). Sen-
sitivity analyses were conducted by excluding outlier sites
with large confidence intervals.
Institutional review
This study was part of a larger study surveying morbidities
and mortality in Canada, for which ethics approval for
anonymous collation of data was obtained at each indi-
vidual centre.
Results
Patient population and nosocomial infection episodes
16538 infants in the dataset met entry criteria (age less
than 4 days on admission). 765 (23.5%) of 3253 VLBW
infants, and 329 (2.5%) of 13244 HBW infants (41 were
missing birth weight and were excluded), developed at
least one episode of NI. Among VLBW infants who devel-
oped NI, 78.7% had only 1 episode, 16.2% had 2 epi-
sodes, and 5.1% had 3 or more episodes of NI, whereas
among HBW infants, 87.9% had 1 episode, 9.3% had 2
episodes, and 2.8% had 3 or more episodes of NI. The
median onset of the first infection from day of admission
was at 19 days for VLBW infants and 15 days for HBW
infants.
Organisms and antibiotics
Among infants with the first episode of NI, the incidence
of CSF culture positive infections was 3.7% in VLBW
infants, and 2.8% in HBW infants. The most common
organism obtained from blood culture was coagulase neg-
ative Staphylococcus (72% of isolates in VLBW, and 57%
in HBW). The same was true of CSF isolates (68% and
41% respectively). Gram-negative organisms were the
next most common pathogen in VLBW, whereas Gram
positives, particularly group B Streptococcus, was the next
most prevalent in HBW.
Ninety percent of VLBW infants and 73.3% of HBW
infants received at least one course of antibiotics in the
NICU on either day 1 and / or day 3, as recorded by NTISS
Infant characteristics and therapy related factors
Among VLBW infants, bivariate analysis showed that
infants with NI were more likely to be outborn, delivered
by vaginal birth, and have 5 minute Apgar score <7, but
less likely to be SGA (see Table 1). Infants with NI also
had significantly lower birth weight and gestational age,
and higher mean day 1 SNAP-II score, than those without
NI. A number of therapy related risk factors were signifi-
cantly associated with NI: these included use of assisted
ventilation, peripheral IV access, central venous access,
arterial line access, use of antibiotics (on day 1 and/or day
3), gavage feeding, IV amino acid, and IV fat. For HBW
infants, NI was associated with similar infant characteris-
tics, but also with congenital anomalies, 5 minute Apgar
score <7, and higher SNAP-II score. Correlation between
variables: NI has significant correlation with all variables
identified except for antibiotic use. However, when strati-
fied by birth weight, antibiotic use has significant correla-
tion with NI for HBW infants. The Spearman correlation
coefficient between CVL and parenteral nutrition is 0.26,
which is significant. Furthermore, a cross-tabulation of NI
by CVL controlling for IV parenteral nutrition (TPN) indi-
cates significant correlation beween NI and CVL and a
contingency coefficient of 0.1 for either TPN present or
absent. Therefore, there is no evidence that the presence of
TPN or CVL in the models renders the other redundant.
Mortality and morbidity
Mortality was more strongly associated with the NI group
compared to the group without NI for HBW infants, but
not for VLBW infants. Major morbidities (necrotizing
enterocolitis, chronic lung disease at 36 weeks post-men-
strual age, severe intraventricular hemorrhage/periven-
tricular lesions, and severe stages (3 and 4) of retinopathy
of prematurity) were more common in the NI group
(Table 2).BMC Pediatrics 2005, 5:22 http://www.biomedcentral.com/1471-2431/5/22
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Risk factors predictive of nosocomial infection on 
multivariable logistic regression
In VLBW infants, factors associated with NI in the multi-
variable logistic model were: gestational age, use of
assisted ventilation and IV fat and, and outborn status (see
table 3). Ninety-nine percent of infants receiving IV fat
also received IV amino acid, so these interventions were
combined. SNAP-II scores were combined into ≥ 10 and
0–9 (the reference) groups because the parameters for the
higher score groups [10–19, 20–29, > = 30) appeared to
be similar. Compared to infants with a gestational age of
greater than 28 weeks, lower gestation was increasingly
more likely to be associated with NI. SNAP-II score ≥ 10
was of borderline significance.
In HBW infants, factors associated (p < 0.05) with NI in
the multivariable logistic model were: gestational age, use
of central venous access, peripheral intravenous access,
and use of IV fat or IV amino acid, assisted ventilation,
outborn status, use of antibiotics and presence of congen-
ital anomalies. Again, IV fat and IV amino acid could be
used interchangeably in the model. Infants who received
parenteral nutrition were more likely to have NI. Central
venous access was associated with higher risk for NI, as
was use of peripheral IV access.
Variations in nosocomial infection rates among NICUs: site 
comparisons
For VLBW infants, cross-tabulation of site and NI showed
significant variation between sites (chi-square = 248.7, df
= 16, P < 0.001). Crude rates of NI ranged from 6.7% to
74.5% of infants having at least one episode of NI. The
crude incidences of NI for 8 hospitals were significantly (p
< 0.05) different from the reference hospital (site O) (Fig-
ure 1). Site variations persisted after adjustment for base-
line patient risk factors (gestational age, admission day
SNAP-II score, outborn status) using multivariate logistic
regression analysis (Figure 1), with the highest odds ratio
Table 1: Characteristics of infants with and without nosocomial infections (NI), for birth weights less than 1500 g and 1500 g or more 
(asterisks indicate significant difference at p < 0.05 level between infants with and without NI in each birthweight group)
Birth weight Less than 1500 g 1500 g or more
Characterististics With NI (n = 765) Without NI (n = 2488) With NI (n = 329) Without NI (n = 13244)
Gestation (mean weeks ± sd) 27.2 +/- 2.3 28.8 +/- 2.8* 35.8 +/- 3.6 36.3 +/- 3.2*
Birth weight (mean gm ± sd) 957 +/- 259 1010 +/- 267* 2611 +/- 806 2758 +/- 796*
Day 1 SNAP-II (mean ± sd) 18.2 +/- 12.5 14.1 +/- 13.0* 11.9 +/- 12.5 4.9 +/- 8.5*
Small for gestational age (%) 9.7 12.6* 2.8 2.7
Antenatal steroids (%) 71.4 68.2 21.1 20.4
Multiple birth (%) 26.7 28.5 7.9 12.5*
Outborn (%) 24.6 12.7* 59.9 23.1*
Male (%) 55.3 51.8 59.9 58.1
Cesarean delivery (%) 47.5 55.2* 38.9 36.3
Maternal hypertension (%) 18.1 19.4 10.4 11.6
Apgar @ 5 mins < 7 (%) 26.9 20.0* 21.4 11.9*
Congenital Anomalies (%) 10.6 7.9* 48.6 10.9*
Table 2: Mortality and morbidity among infants with and without nosocomial infections, for infants with birth weight less than 1500 g 
and 1500 g or more (asterisks indicate significant difference at p < 0.05 level between infants with and without nosocomial infections 
within each birth weight group).
Birthweight Less than 1500 g 1500 g or more
Outcome (%) With NI (n = 765) Without NI (n = 2488) With NI (n = 329) Without NI (n = 12915)
Mortality 8.7 8.6 8.5 1.3*
Necrotizing enterocolitis 13.4 4.4* 8.8 0.4*
Chronic lung disease 38.7 18.5* 25.7 4.4*
Severe intraventricular hemorrhage 10.5 8.2* 5.3 2.8*
Severe retinopathy of prematurity 14.6 8.1* 0.0 0.0
Survival without major morbidity 46.3 69.5* 74.8 96.0*BMC Pediatrics 2005, 5:22 http://www.biomedcentral.com/1471-2431/5/22
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being 8.6 (95% confidence interval (CI) 4.1 to 18.2), and
the lowest 0.2 (95% CI 0.1 to 0.4) when compared to the
reference site (Figure 1).
For HBW infants, significant variation was also present
between sites (chi-square = 360.0, df = 16, P < 0.001).
Crude rates of NI ranged from 0.1% to 17.0 %. When only
site variables were in the regression model, 6 hospitals
had significantly different (p < 0.05) NI rates from the ref-
erence hospital (F). Significant site differences largely cor-
rected after adjustment for baseline population risks
(gestational age, admission day SNAP-II score, outborn
status) (Figure 2).
Comparison of Figures 1 and 2 shows that hospitals with
low and high incidences of NI among VLBW infants also
tended to have lower and higher incidences of NI among
larger infants. When sites P and N were excluded from the
analysis, site A was also found to have significantly higher
incidence of NI than the median hospital for both VLBW
and HBW infants. (Figures 3 and 4)
Discussion
The above results represent data from 17 tertiary NICUs,
making up approximately three-quarters of level III neo-
natal cots in Canada. Canada has publicly-funded health
care with a highly regionalized neonatal-perinatal care
system in which each tertiary NICU is the referral centre
for its geographic region. Consequently, our results
approximate a population-based study for three quarters
of the Canadian population.
The bivariate analysis suggests that infants who experience
at least one episode of nosocomial bacteremia or nosoco-
mial bacterial meningitis are smaller, more preterm, and
had higher illness severity on admission. They have lower
5-minute Apgar scores and are more likely to have been
transported from another centre. VLBW infants with NI
were more likely to have been delivered vaginally. Noso-
comial infection rates will vary from institution to institu-
tion if these demographic factors vary from region to
region. Adjusted data, to some extent, correct for these
geographic variations.
Our data show that significant variations in nosocomial
infection do occur between units, with crude rates ranging
6.7% to 74.5% among VLBW infants, and 0.1% to 17.0%
among HBW infants. These variations persist after adjust-
ment for gestation, outborn status and admission illness
severity. These findings are not unique to hospital
acquired infections: using data from the same population
of infants, other authors have identified between-site var-
iations in the crude and adjusted rates of both mortality
and a number of major neonatal morbidities, including
chronic lung disease, retinopathy of prematurity, catheter-
related sepsis and intraventricular lesions [6-8,10,18].
There seems little doubt that these differences in outcome
exist, the important question remains as to the underlying
reasons for the differences.
Multivariate analysis suggests that, in addition to gesta-
tion and acuity, a number of therapeutic interventions are
associated with nosocomial infection. These include
mechanical ventilation, vascular access (central and
peripheral), and parenteral nutrition. These factors are
predictive in cohorts of both VLBW and HBW babies –
supporting their place as clinically significant risks factors
for NI. The preponderance of NI among HBW babies with
congenital anomalies may reflect surgical interventions,
or the possibility of immunocompromise. We recognize
that there are likely to be other, unrecorded demographic
factors or interventions, that may account for risk, such as
feeding practices or ethnicity – these remain unaccounted
for in our study.
Table 3: Risk factors associated with nosocomial infection on multivariate analysis, for infants with birth weight less than 1500 g and 
1500 g or more
Birth weight Less than 1500 g Odds Ratio (95% 
confidence intervals)
1500 g or more Odds Ratios (95% 
confidence intervals)
Gestation ≤ 24 weeks 2.7 (1.4 – 5.3) 4.0 (0.5 – 32.7)
Gestation 25–28 weeks 2.2 (1.2 – 4.1) 6.1 (1.6 – 23.1)
Gestation 29–32 weeks 1.1 (0.6 – 2.0) 1.9 (1.3 – 2.6)
SNAP II ≥ 10 1.2 (1.0 – 1.6) 1.0 (0.8 – 1.3)
Peripheral intravenous line 0.9 (0.7 – 1.1) 1.9 (1.1 – 3.2)
Central venous Line 0.9 (0.8 – 1.2) 1.6 (1.2 -2.1)
Assisted ventilation 1.5 (1.1 – 2.0) 2.9 (1.9 – 4.6)
Parenteral nutrition 3.9 (3.0 – 5.2) 5.1 (3.8 – 6.9)
Outborn status 2.0 (1.6 – 2.5) 1.9 (1.4 – 2.6)
Use of antibiotics 0.9 (0.4 – 2.3) 2.9 (1.6 – 5.0)
Congenital anomalies 1.2 (0.9 – 1.6) 2.9 (2.2 – 3.8)BMC Pediatrics 2005, 5:22 http://www.biomedcentral.com/1471-2431/5/22
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Crude and risk adjusted odds ratios of nosocomial infection rates by hospital for infants <1500 g birth weight (point estimates  and 95% confidence interval limits shown) Figure 1
Crude and risk adjusted odds ratios of nosocomial infection rates by hospital for infants <1500 g birth weight (point estimates 
and 95% confidence interval limits shown). Adjustment is for gestational age, admission day SNAP-II score, and outborn status. 
Site O, the site closest to the median risk, was used as the reference site.
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Crude and risk adjusted odds ratios of nosocomial infection rates by hospital for infants ≥ 1500 g birth weight (point estimates  and 95% confidence interval limits shown) Figure 2
Crude and risk adjusted odds ratios of nosocomial infection rates by hospital for infants ≥ 1500 g birth weight (point estimates 
and 95% confidence interval limits shown). Adjustment is for gestational age, admission day SNAP-II score, and outborn status. 
Site O, the site closest to the median risk, was used as the reference site.
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Crude and risk adjusted odds ratios of nosocomial infection rates by hospital (with sites P and N excluded) for infants <1500 g  birth weight (point estimates and 95% confidence interval limits shown) Figure 3
Crude and risk adjusted odds ratios of nosocomial infection rates by hospital (with sites P and N excluded) for infants <1500 g 
birth weight (point estimates and 95% confidence interval limits shown). Adjustment is for gestational age, admission day 
SNAP-II score, and outborn status.
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Crude and risk adjusted odds ratios of nosocomial infection rates by hospital (with sites P and N excluded) for infants ≥ 1500 g  birth weight (point estimates and 95% confidence interval limits shown) Figure 4
Crude and risk adjusted odds ratios of nosocomial infection rates by hospital (with sites P and N excluded) for infants ≥ 1500 g 
birth weight (point estimates and 95% confidence interval limits shown). Adjustment is for gestational age, admission day 
SNAP-II score, and outborn status.
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There is little doubt from this study that nosocomial infec-
tion is associated with significant in-hospital morbidity,
but the results on mortality are more subtle. Unadjusted
mortality in VLBW infants was not increased by an epi-
sode of nosocomial sepsis. A possible explanation is that
the effect size is small because most deaths among VLBW
infants occur in the first few days of life from other causes,
for example cardiorespiratory failure, whereas NI occurs
more commonly at a later age. In addition, coagulase neg-
ative staphylococcal infections (the commonest isolate in
NICU) are reported to have a relatively low mortality in
VLBW infants (2% or less in three large cohort studies [19-
21]), making a small contribution to overall mortality
that may not achieve statistical significance.
Between-site analysis confirmed that inter-NICU variation
in NI rates persisted after risk adjustment for birth weight,
gestation and illness severity in VLBW infants. The 3 sites
with lower than median incidence of NI for VLBW infants,
also had a lower incidence of NI for HBW infants. Three
out of 4 sites with higher than median incidence of NI for
HBW infants also had higher incidence of NI for VLBW
infants. The impression that overall site performance is
consistent for infants at different birth weight groups sup-
ports the contention that factors other that those recorded
and adjusted for in this study, probably related to inter-
ventions or the NICU environment, contribute to the risk
of nosocomial infection – especially in VLBW infants,
with whom most of the burden of NI lies.
We have seen that nosocomial infection rates vary across
Canada and are significantly affected by clinical interven-
tions. However, a number of important factors have not
been adjusted for, particularly those related to organism
virulence or infectivity, and population susceptibility.
One could hypothesize that organism virulence or infec-
tivity varies across the country, as does the susceptibility
of population groups. There is some evidence to support
variation in genetic susceptibility: Ahrens et al [22]
reported that VLBW neonates with specific CD14 gene
mutations had a greater rate of neonatal sepsis than those
without. A more detailed study of population demo-
graphics and organism subtypes may reveal whether these
factors impact on nosocomial infection rates. Similarly,
environmental factors such as unit layout and clinical
practices may affect nosocomial infection rates – the
extensive list of potential confounders may require an
alternative research methodology to discover association
and/or causation. Bloom et al [23] reported decreased
rates of nosocomial infections by sharing information
about differences between NICUs with high and low
nosocomial infection rates, and addressing these varia-
tions in clinical practice. The Canadian Neonatal Network
is embarking on a multicentre study to examine the effect
of multiple evidence-based practice interventions on
nosocomial infection rates, which will hopefully answer
some of these questions.
A limitation of our study is that it is possible that some
positive blood or CSF cultures are in fact false positives.
Struthers et al [24] estimated that 5% of positive blood
cultures were false, suggesting that the vast majority of
confirmed bacteremia is true. However, it might be argued
that even false positive results represent a significant bur-
den of illness, and including these episodes may fairly rep-
resent this burden. Another limitation of this type of
observational study is the difficulty in differentiating
cause and effect. The observational data in this study were
presented using univariate, unadjusted and risk-adjusted
multivariate models. Unfortunately, these analyses
cannot account for the temporal relationships between
events, nor do they adjust for risk factors that are not
included in data collection. However, the strengths of the
logistic regression model are its robustness and extensive
use in similar studies. Future studies should take temporal
relationships into account, permitting time-sensitive anal-
ysis, better inference of cause and effect, and assessment of
attributable risk.
Conclusion
Rates of nosocomial infection in Canadian NICUs vary
considerably, even after correction for known risk factors.
The data suggest that this variation is due, in part, to dif-
ferences in clinical practices, and therefore may be amena-
ble to interventions that alter practice. More study, and
alternative study designs, may be required to evaluate
contributing factors and effect practice change.
Canadian Neonatal Network
Shoo K. Lee (Coordinator, Canadian Neonatal Network;
Centre for Healthcare Innovation and Improvement, Van-
couver, BC); Wayne Andrews (Charles A. Janeway Child
Health Centre, St John's, NF); Ranjit Baboolal (North
York Hospital, N. York, ON); Jill Boulton (St Joseph's
Health Centre, London, ON; previously Mt Sinai Hospi-
tal, Toronto, ON); David Brabyn (Royal Columbian Hos-
pital, New Westminster, BC); David S.C. Lee (St Joseph's
Health Centre; London, ON); Derek Matthew (Victoria
General Hospital (Victoria, BC); Douglas D. McMillan
(IWK-Grace Health Centre for Women, Children and
Families, Halifax, NS; formerly Foothills Hospital,
Calgary, AB); Christine Newman (Hospital for Sick Chil-
dren; Toronto, ON); Arne Ohlsson (Mt Sinai Hospital,
Toronto, ON; formerly Women's College Hospital,
Toronto, ON); Abraham Peliowski (Royal Alexandra Hos-
pital, Edmonton, AB); Margaret Pendray (Children's &
Women's Health Centre of British Columbia (Vancouver,
BC); Koravangattu Sankaran (Royal University Hospital,
Saskatoon, SK); Barbara Schmidt (Hamilton Health Sci-
ences Corporation, Hamilton, ON); Mary Seshia (HealthBMC Pediatrics 2005, 5:22 http://www.biomedcentral.com/1471-2431/5/22
Page 11 of 12
(page number not for citation purposes)
Sciences Centre, Winnipeg, MB); Anne Synnes (Children's
and Women's Health Centre of British Columbia, Van-
couver, BC; formerly Montreal Children's Hospital, Mon-
treal, PQ); Paul Thiessen (Children's & Women's Health
Centre of British Columbia, Vancouver, BC); Robin
Walker (Children's Hospital of Eastern Ontario and
Ottawa General Hospital, Ottawa, ON); Robin Whyte
(IWK-Grace Health Centre for Women, Children and
Families, Halifax, NS).
Coordinating centre staff
Holly Bavinton; Stella Karuri; Zhenguo Qiu; Sarka Lisonk-
ova, Shawn Stewart.
Abbreviations
Nosocomial infection (NI)
Neonatal Intensive Care Unit (NICU)
Score for Neonatal Acute Physiology, Version II (SNAP-II)
Neonatal Therapeutic Intensity Scoring System (NTISS)
Very low birth weight (VLBW)
Higher birth weight (HBW)
Cerebrospinal fluid (CSF)
Standard deviation (SD)
Confidence interval (CI)
Competing interests
The author(s) declare that they have no competing
interests.
Authors' contributions
KA interpreted data and drafted the manuscript. DDM,
WA and MP were site investigators. ZQ performed statisti-
cal analysis and interpretation. SKL was the principal
investigator and drafted the manuscript. All these individ-
uals read and approved the final manuscript. The CNN
represents all site investigators, and was responsible for
organization and administration of the SNAP study, and
subsequent data flow.
Acknowledgements
Ruth Little for editorial assistance and Li-Yin Chien for assistance with data 
analysis.
This study was supported by Grant 40503 and Grant 00152 from the Med-
ical Research Council of Canada. Additional funding was provided by the 
B.C.'s Children's Hospital Foundation; Calgary Regional Health Authority; 
Dalhousie University Neonatal-Perinatal Research Fund; Division of 
Neonatology, Children's Hospital of Eastern Ontario; Child Health Pro-
gram, Health Care Corporation of St John's; The Neonatology Program, 
Hospital for Sick Children; Lawson Research Institute; Midland Walwyn 
Capital Inc; Division of Neonatology, Hamilton Health Sciences Corpora-
tion; Mount Sinai Hospital; North York General Hospital Foundation; Saint 
Joseph's Health Centre; University of Saskatchewan Neonatal Research 
Fund; University of Western Ontario; Women's College Hospital.
References
1. Stoll BJ, Gordon T, Korones SB, Shankaran S, Tyson JE, Bauer CR,
Fanaroff AA, Lemons JA, Donovan EF, Oh W, Stevenson DK, Ehrenk-
ranz RA, Papile LA, Verter J, Wright LL: Late-onset sepsis in very
low birth weight neonates: a report from the National Insti-
tute of Child Health and Human Development Neonatal
Research Network.  J Pediatr 1996, 129(1):63-71.
2. Stoll BJ, Hansen N, Fanaroff AA, Wright L, Carlo WA, Ehrenkranz
RA, Lemons JA, Donovan EF, Stark AR, Tyson JE, Oh W, Bauer CR,
Korones SB, Shankaran S, Laptook AR, Stevenson DK, Papile LA,
Poole WK: Late-onset sepsis in very low birth weight
neonates: the experience of the NICHD Neonatal Research
Network.  Pediatrics 2002, 110(2 Pt 1):285-91.
3. Stevenson DK, Wright LL, Lemons JA, Oh W, Korones SB, Papile LA,
Bauer CR, Stoll BJ, Tyson JE, Shankaran S, Fanaroff AA, Donovan EF,
Ehrenkranz RA, Verter J: Very low birth weight outcomes of the
National Institute of Child Health and Human Development
Neonatal Research Network, January 1993 through Decem-
ber 1994.  Am J Obstet Gynecol 1998, 179:1632-1639.
4. Brodie SB, Sands KE, Gray JE, Parker RA, Goldmann DA, Davis R,
Richardson DK: Occurrence of nosocomial bloodstream infec-
tions in six neonatal intensive care units.  Pediatr Infect Dis J
2000, 19(1):56-65.
5. Horbar JD, Badger J, Lewit EM, Rogowski J, Shiono PH: Hospital and
patient characteristics associated with variation in 28-day
mortality rates for very low birth weight infants.  Pediatrics
1997, 99:149-156.
6. Sankaran K, Chien LY, Walker R, Seshia M, Ohlsson A, Lee SK, The
Canadian Neonatal Network: Variations in mortality rates
among Canadian neonatal intensive care units.  CMAJ 2002,
166:173-178.
7. Chien LY, McNab Y, Aziz K, Andrews W, McMillan DD, Lee SK, The
Canadian Neonatal Network: Variations in central venous cath-
eter related infection risks among Canadian neonatal inten-
sive care units.  Pediatr Infect Dis J 2002, 21:505-511.
8. Synnes A, Chien LY, Peliowski A, Baboolal R, Lee SK, The Canadian
Neonatal Network: Variations in Intraventricular Hemorrhage
Incidence Rates among Canadian Neonatal Intensive Care
Units.  J Pediatr 2001, 138:525-531.
9. Edwards WH: Preventing nosocomial bloodstream infection
in very low birth weight infants.  Semin Neonatol 2002,
7(4):325-33.
10. Lee SK, McMillan D, Ohlsson A, Pendray M, Synnes A, Whyte R,
Chien LY, Sale J, the Canadian Neonatal Network: Variations in
practice and outcomes of the Canadian NICU Network :
1996–7.  Pediatrics 2000, 106:1070-9.
11. Statistics Canada. Births and birth rate   [http://www.statcan.ca/
english/Pgdb/People/Population/demo04a.htm]. Accessed February
23, 2001
12. Statistics Canada. Population   [http://www.statcan.ca/english/
Pgdb/People/Population/demo02.htm]. Accessed February 23, 2001
13. Chien LY, MacNab Y, Aziz K, Andrews W, McMillan DD, Lee SK, the
Canadian Neonatal Network: Variations in central venous cath-
eter-related infection risks among Canadian neonatal inten-
sive care units.  Pediatr Infect Dis J 2002, 21:505.
14. The Canadian Neonatal Network™: The Canadian Neonatal
Network™ Data Abstractor's Manual.  Vancouver, B.C; 1996. 
15. Whitfield M: British Columbia Provincial Growth Chart.  Van-
couver, Canada: British Columbia Children's Hospital; 1996. 
16. Richardson DK, Corcoran JD, Escobar GJ, Lee SK: SNAP-II and
SNAPPE-II : Simplified newborn illness severity and mortal-
ity risk scores.  J Pediatr 2001, 138(1):92-100.
17. Gray JE, Richardson DK, McCormick MC, Workman-Daniels K,
Goldmann DA: Neonatal therapeutic intervention scoring sys-
tem: a therapy-based severity-of-illness index.  Pediatrics 1992,
90(4):561-7.Publish with BioMed Central    and   every 
scientist can read your work free of charge
"BioMed Central will be the most significant development for 
disseminating the results of biomedical research in our lifetime."
Sir Paul Nurse, Cancer Research UK
Your research papers will be:
available free of charge to the entire biomedical community
peer reviewed and published  immediately upon acceptance
cited in PubMed and archived on PubMed Central 
yours — you keep the copyright
Submit your manuscript here:
http://www.biomedcentral.com/info/publishing_adv.asp
BioMedcentral
BMC Pediatrics 2005, 5:22 http://www.biomedcentral.com/1471-2431/5/22
Page 12 of 12
(page number not for citation purposes)
18. Ohlsson A, Synnes AR, Seshia MMK, Newman CJ, Schmidt B, Chien
LY, Lee SK: Variations in the Site Specific Rates of Bronchop-
ulmonary Dysplasia (BPD) among Infants Admitted to 17
Neonatal Intensive Care Units (NICUs) in Canada – Implica-
tions for Bench Marking.  Pediatr Res 2000, 47(4):371A.
19. Isaacs D: A ten year, multicentre study of coagulase negative
staphylococcal infections in Australasian neonatal units.  Arch
Dis Child Fetal Neonatal Ed 2003, 88:F89-F93.
20. Karlowicz MG, Buescher ES, Surka AE: Fulminant late-onset sep-
sis in a neonatal intensive care unit, 1988-and the impact of
avoiding empiric vancomycin therapy.  Pediatrics 2000,
106(6):1387-90.
21. Stoll BJ, Hansen N, Fanaroff AA, Wright LL, Carlo WA, Ehrenkranz
RA, Lemons JA, Donovan EF, Stark AR, Tyson JE, Oh W, Bauer CR,
Korones SB, Shankaran S, Laptook AR, Stevenson DK, Papile LA,
Poole WK: Late-onset sepsis in very low birth weight
neonates: the experience of the NICHD Neonatal Research
Network.  Pediatrics 2002, 110(2 Pt 1):285-91.
22. Ahrens P, Kattner E, Köhler B, Härtel C, Seidenberg J, Segerer H,
Moller J, Gopel W: Genetic Factors in Neonatology Study
Group. Mutations of genes involved in the innate immune
system as predictors of sepsis in very low birth weight
infants.  Pediatr Res 2004, 55:652-656.
23. Bloom BT, Craddock A, Delmore PM, Kurlinski JP, Voeloker M, Land-
fish N, Rodriguez-Pierce M, Swanton D, Rossi J, Ehlen J, Harmon C,
Deterding J, Houser F: Reducing acquired infections in the
NICU: Observing and implementing meaningful differences
in process between high and low acquired infection rate
centres.  J Perinatol 2003, 23:489-492.
24. Struthers S, Underhill H, Albersheim S, Greenberg D, Dobson S: A
comparison of two versus one blood culture in the diagnosis
and treatment of coagulase-negative staphylococcus in the
neonatal intensive care unit.  J Perinatol 2002, 22:547-549.
Pre-publication history
The pre-publication history for this paper can be accessed
here:
http://www.biomedcentral.com/1471-2431/5/22/prepub